date,title,source
Nov-08-18,Sutro Appoints Industry Veteran Shalini Sharp to Board of Directors,PR Newswire
Nov-13-18,"Sutro Announces IND Submission and Conclusion of 30-Day Review Period for STRO-002, an Antibody-Drug Conjugate (ADC) Targeting Anti-Folate Receptor- for Treatment of Ovarian and Endometrial Cancer",PR Newswire
Nov-14-18,Sutro Biopharma Reports Third Quarter 2018 Financial Results,PR Newswire
Nov-26-18,Sutro to Participate in the 30th Annual Piper Jaffray Healthcare Conference,PR Newswire
Dec-19-18,Sutro Achieves $10 Million Milestone Payment from Celgene,PR Newswire
Dec-20-18,"DAFNA Capital Management Return, AUM and Holdings",Insider Monkey
